Eptinezumab: Effective Long-Term Relief for Chronic Migraines

Research Summary

A recent study published in the Journal of Headache and Pain investigates the long-term use of eptinezumab, a treatment for chronic migraine, in Japanese adults. The 60-week open-label SUNSET trial focused on both the tolerability and effectiveness of the drug. The study found that eptinezumab was generally well-tolerated and effective over the long term. Participants experienced a reduction in the frequency of migraine days, highlighting the potential for sustained migraine relief. This research provides valuable insights into the use of eptinezumab for chronic migraine management in Japanese adults, emphasizing its promise as a viable long-term treatment option.

Study Details

📄 Title: Long-term tolerability and effectiveness of eptinezumab in Japanese adults with chronic migraine: results of the 60-week open-label SUNSET trial.

👥 Research Team: Takeshima T et al.

📚 Published In: J Headache Pain

📅 Publication Date: 2025 Nov 22

⚕️ Medical Disclaimer: This summary is generated automatically from recent migraine research. Always consult with healthcare professionals for medical advice.